Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 96

1.

Strengthening Noncommunicable Disease Research Capacity and Chronic Disease Outcomes in Low- and Middle-Income Countries in South Asia: Implementation and Evaluation of the ASCEND Program.

Byrnes A, Haregu TN, Pasricha N, Singh K, Thirunavukkarasu S, Wickkramasinghe K, Thankappan KR, Oldenburg B.

Asia Pac J Public Health. 2019 Sep;31(6):536-547. doi: 10.1177/1010539519867791. Epub 2019 Aug 13.

PMID:
31409121
2.

SynGO: An Evidence-Based, Expert-Curated Knowledge Base for the Synapse.

Koopmans F, van Nierop P, Andres-Alonso M, Byrnes A, Cijsouw T, Coba MP, Cornelisse LN, Farrell RJ, Goldschmidt HL, Howrigan DP, Hussain NK, Imig C, de Jong APH, Jung H, Kohansalnodehi M, Kramarz B, Lipstein N, Lovering RC, MacGillavry H, Mariano V, Mi H, Ninov M, Osumi-Sutherland D, Pielot R, Smalla KH, Tang H, Tashman K, Toonen RFG, Verpelli C, Reig-Viader R, Watanabe K, van Weering J, Achsel T, Ashrafi G, Asi N, Brown TC, De Camilli P, Feuermann M, Foulger RE, Gaudet P, Joglekar A, Kanellopoulos A, Malenka R, Nicoll RA, Pulido C, de Juan-Sanz J, Sheng M, Südhof TC, Tilgner HU, Bagni C, Bayés À, Biederer T, Brose N, Chua JJE, Dieterich DC, Gundelfinger ED, Hoogenraad C, Huganir RL, Jahn R, Kaeser PS, Kim E, Kreutz MR, McPherson PS, Neale BM, O'Connor V, Posthuma D, Ryan TA, Sala C, Feng G, Hyman SE, Thomas PD, Smit AB, Verhage M.

Neuron. 2019 Jul 17;103(2):217-234.e4. doi: 10.1016/j.neuron.2019.05.002. Epub 2019 Jun 3.

PMID:
31171447
3.

Implementation science approaches to enhance uptake of complex interventions in surgical settings.

Byrnes A, Mudge A, Clark D.

Aust Health Rev. 2019 Apr 15. doi: 10.1071/AH18193. [Epub ahead of print]

PMID:
30982502
4.

Asterless is a Polo-like kinase 4 substrate that both activates and inhibits kinase activity depending on its phosphorylation state.

Boese CJ, Nye J, Buster DW, McLamarrah TA, Byrnes AE, Slep KC, Rusan NM, Rogers GC.

Mol Biol Cell. 2018 Nov 15;29(23):2874-2886. doi: 10.1091/mbc.E18-07-0445. Epub 2018 Sep 26.

5.

Prospective application of an implementation framework to improve postoperative nutrition care processes: Evaluation of a mixed methods implementation study.

Byrnes A, Young A, Mudge A, Banks M, Clark D, Bauer J.

Nutr Diet. 2018 Sep;75(4):353-362. doi: 10.1111/1747-0080.12464. Epub 2018 Aug 28.

PMID:
30151938
6.

EXploring practice gaps to improve PERIoperativE Nutrition CarE (EXPERIENCE Study): a qualitative analysis of barriers to implementation of evidence-based practice guidelines.

Byrnes A, Young A, Mudge A, Banks M, Bauer J.

Eur J Clin Nutr. 2019 Jan;73(1):94-101. doi: 10.1038/s41430-018-0276-x. Epub 2018 Aug 14.

PMID:
30108281
7.

Early post-operative diet upgrade in older patients may improve energy and protein intake but patients still eat poorly: an observational pilot study.

Byrnes A, Worrall J, Young A, Mudge A, Banks M, Bauer J.

J Hum Nutr Diet. 2018 Dec;31(6):818-824. doi: 10.1111/jhn.12572. Epub 2018 Jun 27.

PMID:
29952057
8.

Quantifying the Impact of Rare and Ultra-rare Coding Variation across the Phenotypic Spectrum.

Ganna A, Satterstrom FK, Zekavat SM, Das I, Kurki MI, Churchhouse C, Alfoldi J, Martin AR, Havulinna AS, Byrnes A, Thompson WK, Nielsen PR, Karczewski KJ, Saarentaus E, Rivas MA, Gupta N, Pietiläinen O, Emdin CA, Lescai F, Bybjerg-Grauholm J, Flannick J; GoT2D/T2D-GENES Consortium, Mercader JM, Udler M; SIGMA Consortium Helmsley IBD Exome Sequencing Project; FinMetSeq Consortium; iPSYCH-Broad Consortium, Laakso M, Salomaa V, Hultman C, Ripatti S, Hämäläinen E, Moilanen JS, Körkkö J, Kuismin O, Nordentoft M, Hougaard DM, Mors O, Werge T, Mortensen PB, MacArthur D, Daly MJ, Sullivan PF, Locke AE, Palotie A, Børglum AD, Kathiresan S, Neale BM.

Am J Hum Genet. 2018 Jun 7;102(6):1204-1211. doi: 10.1016/j.ajhg.2018.05.002. Epub 2018 May 31.

9.

Use of hand grip strength in nutrition risk screening of older patients admitted to general surgical wards.

Byrnes A, Mudge A, Young A, Banks M, Bauer J.

Nutr Diet. 2018 Nov;75(5):520-526. doi: 10.1111/1747-0080.12422. Epub 2018 Apr 16.

PMID:
29663632
10.

Heritability enrichment of specifically expressed genes identifies disease-relevant tissues and cell types.

Finucane HK, Reshef YA, Anttila V, Slowikowski K, Gusev A, Byrnes A, Gazal S, Loh PR, Lareau C, Shoresh N, Genovese G, Saunders A, Macosko E, Pollack S; Brainstorm Consortium, Perry JRB, Buenrostro JD, Bernstein BE, Raychaudhuri S, McCarroll S, Neale BM, Price AL.

Nat Genet. 2018 Apr;50(4):621-629. doi: 10.1038/s41588-018-0081-4. Epub 2018 Apr 9.

11.

Corrigendum: Landscape of X chromosome inactivation across human tissues.

Tukiainen T, Villani AC, Yen A, Rivas MA, Marshall JL, Satija R, Aguirre M, Gauthier L, Fleharty M, Kirby A, Cummings BB, Castel SE, Karczewski KJ, Aguet F, Byrnes A, Consortium G, Lappalainen T, Regev A, Ardlie KG, Hacohen N, MacArthur DG.

Nature. 2018 Mar 7;555(7695):274. doi: 10.1038/nature25993.

PMID:
29517003
12.

An ordered pattern of Ana2 phosphorylation by Plk4 is required for centriole assembly.

McLamarrah TA, Buster DW, Galletta BJ, Boese CJ, Ryniawec JM, Hollingsworth NA, Byrnes AE, Brownlee CW, Slep KC, Rusan NM, Rogers GC.

J Cell Biol. 2018 Apr 2;217(4):1217-1231. doi: 10.1083/jcb.201605106. Epub 2018 Mar 1.

13.

Hexons from adenovirus serotypes 5 and 48 differentially protect adenovirus vectors from neutralization by mouse and human serum.

Harmon AW, Moitra R, Xu Z, Byrnes AP.

PLoS One. 2018 Feb 5;13(2):e0192353. doi: 10.1371/journal.pone.0192353. eCollection 2018.

14.

Enhanced Recovery After Surgery as an auditing framework for identifying improvements to perioperative nutrition care of older surgical patients.

Byrnes A, Banks M, Mudge A, Young A, Bauer J.

Eur J Clin Nutr. 2018 Jun;72(6):913-916. doi: 10.1038/s41430-017-0049-y. Epub 2017 Dec 29.

PMID:
29288246
15.

Stu2 uses a 15-nm parallel coiled coil for kinetochore localization and concomitant regulation of the mitotic spindle.

Haase KP, Fox JC, Byrnes AE, Adikes RC, Speed SK, Haase J, Friedman B, Cook DM, Bloom K, Rusan NM, Slep KC.

Mol Biol Cell. 2018 Feb 1;29(3):285-294. doi: 10.1091/mbc.E17-01-0057. Epub 2017 Nov 29.

16.

Landscape of X chromosome inactivation across human tissues.

Tukiainen T, Villani AC, Yen A, Rivas MA, Marshall JL, Satija R, Aguirre M, Gauthier L, Fleharty M, Kirby A, Cummings BB, Castel SE, Karczewski KJ, Aguet F, Byrnes A; GTEx Consortium; Laboratory, Data Analysis &Coordinating Center (LDACC)—Analysis Working Group; Statistical Methods groups—Analysis Working Group; Enhancing GTEx (eGTEx) groups; NIH Common Fund; NIH/NCI; NIH/NHGRI; NIH/NIMH; NIH/NIDA; Biospecimen Collection Source Site—NDRI; Biospecimen Collection Source Site—RPCI; Biospecimen Core Resource—VARI; Brain Bank Repository—University of Miami Brain Endowment Bank; Leidos Biomedical—Project Management; ELSI Study; Genome Browser Data Integration &Visualization—EBI; Genome Browser Data Integration &Visualization—UCSC Genomics Institute, University of California Santa Cruz, Lappalainen T, Regev A, Ardlie KG, Hacohen N, MacArthur DG.

Nature. 2017 Oct 11;550(7675):244-248. doi: 10.1038/nature24265. Erratum in: Nature. 2018 Mar 7;555(7695):274.

17.

Heterogeneous contribution of microdeletions in the development of common generalised and focal epilepsies.

Pérez-Palma E, Helbig I, Klein KM, Anttila V, Horn H, Reinthaler EM, Gormley P, Ganna A, Byrnes A, Pernhorst K, Toliat MR, Saarentaus E, Howrigan DP, Hoffman P, Miquel JF, De Ferrari GV, Nürnberg P, Lerche H, Zimprich F, Neubauer BA, Becker AJ, Rosenow F, Perucca E, Zara F, Weber YG, Lal D.

J Med Genet. 2017 Sep;54(9):598-606. doi: 10.1136/jmedgenet-2016-104495. Epub 2017 Jul 29.

18.

Evaluating the Impact of Natural IgM on Adenovirus Type 5 Gene Therapy Vectors.

Xu Z, Tian J, Harmon AW, Byrnes AP.

Methods Mol Biol. 2017;1643:187-196. doi: 10.1007/978-1-4939-7180-0_15.

PMID:
28667539
19.

TOG-tubulin binding specificity promotes microtubule dynamics and mitotic spindle formation.

Byrnes AE, Slep KC.

J Cell Biol. 2017 Jun 5;216(6):1641-1657. doi: 10.1083/jcb.201610090. Epub 2017 May 16.

20.

Ultra-rare disruptive and damaging mutations influence educational attainment in the general population.

Ganna A, Genovese G, Howrigan DP, Byrnes A, Kurki M, Zekavat SM, Whelan CW, Kals M, Nivard MG, Bloemendal A, Bloom JM, Goldstein JI, Poterba T, Seed C, Handsaker RE, Natarajan P, Mägi R, Gage D, Robinson EB, Metspalu A, Salomaa V, Suvisaari J, Purcell SM, Sklar P, Kathiresan S, Daly MJ, McCarroll SA, Sullivan PF, Palotie A, Esko T, Hultman C, Neale BM.

Nat Neurosci. 2016 Dec;19(12):1563-1565. doi: 10.1038/nn.4404. Epub 2016 Oct 3.

21.

Corrigendum: Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine.

Gormley P, Anttila V, Winsvold BS, Palta P, Esko T, Pers TH, Farh KH, Cuenca-Leon E, Muona M, Furlotte NA, Kurth T, Ingason A, McMahon G, Ligthart L, Terwindt GM, Kallela M, Freilinger TM, Ran C, Gordon SG, Stam AH, Steinberg S, Borck G, Koiranen M, Quaye L, Adams HH, Lehtimäki T, Sarin AP, Wedenoja J, Hinds DA, Buring JE, Schürks M, Ridker PM, Hrafnsdottir MG, Stefansson H, Ring SM, Hottenga JJ, Penninx BW, Färkkilä M, Artto V, Kaunisto M, Vepsäläinen S, Malik R, Heath AC, Madden PA, Martin NG, Montgomery GW, Kurki MI, Kals M, Mägi R, Pärn K, Hämäläinen E, Huang H, Byrnes AE, Franke L, Huang J, Stergiakouli E, Lee PH, Sandor C, Webber C, Cader Z, Muller-Myhsok B, Schreiber S, Meitinger T, Eriksson JG, Salomaa V, Heikkilä K, Loehrer E, Uitterlinden AG, Hofman A, van Duijn CM, Cherkas L, Pedersen LM, Stubhaug A, Nielsen CS, Männikkö M, Mihailov E, Milani L, Göbel H, Esserlind AL, Christensen AF, Hansen TF, Werge T; International Headache Genetics Consortium, Kaprio J, Aromaa AJ, Raitakari O, Ikram MA, Spector T, Järvelin MR, Metspalu A, Kubisch C, Strachan DP, Ferrari MD, Belin AC, Dichgans M, Wessman M, van den Maagdenberg AM, Zwart JA, Boomsma DI, Smith GD, Stefansson K, Eriksson N, Daly MJ, Neale BM, Olesen J, Chasman DI, Nyholt DR, Palotie A.

Nat Genet. 2016 Sep 28;48(10):1296. doi: 10.1038/ng1016-1296c. No abstract available.

PMID:
27681292
22.

Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine.

Gormley P, Anttila V, Winsvold BS, Palta P, Esko T, Pers TH, Farh KH, Cuenca-Leon E, Muona M, Furlotte NA, Kurth T, Ingason A, McMahon G, Ligthart L, Terwindt GM, Kallela M, Freilinger TM, Ran C, Gordon SG, Stam AH, Steinberg S, Borck G, Koiranen M, Quaye L, Adams HH, Lehtimäki T, Sarin AP, Wedenoja J, Hinds DA, Buring JE, Schürks M, Ridker PM, Hrafnsdottir MG, Stefansson H, Ring SM, Hottenga JJ, Penninx BW, Färkkilä M, Artto V, Kaunisto M, Vepsäläinen S, Malik R, Heath AC, Madden PA, Martin NG, Montgomery GW, Kurki MI, Kals M, Mägi R, Pärn K, Hämäläinen E, Huang H, Byrnes AE, Franke L, Huang J, Stergiakouli E, Lee PH, Sandor C, Webber C, Cader Z, Muller-Myhsok B, Schreiber S, Meitinger T, Eriksson JG, Salomaa V, Heikkilä K, Loehrer E, Uitterlinden AG, Hofman A, van Duijn CM, Cherkas L, Pedersen LM, Stubhaug A, Nielsen CS, Männikkö M, Mihailov E, Milani L, Göbel H, Esserlind AL, Christensen AF, Hansen TF, Werge T; International Headache Genetics Consortium, Kaprio J, Aromaa AJ, Raitakari O, Ikram MA, Spector T, Järvelin MR, Metspalu A, Kubisch C, Strachan DP, Ferrari MD, Belin AC, Dichgans M, Wessman M, van den Maagdenberg AM, Zwart JA, Boomsma DI, Smith GD, Stefansson K, Eriksson N, Daly MJ, Neale BM, Olesen J, Chasman DI, Nyholt DR, Palotie A.

Nat Genet. 2016 Aug;48(8):856-66. doi: 10.1038/ng.3598. Epub 2016 Jun 20. Erratum in: Nat Genet. 2016 Sep 28;48(10 ):1296.

23.

Substitution of blood coagulation factor X-binding to Ad5 by position-specific PEGylation: Preventing vector clearance and preserving infectivity.

Krutzke L, Prill JM, Engler T, Schmidt CQ, Xu Z, Byrnes AP, Simmet T, Kreppel F.

J Control Release. 2016 Aug 10;235:379-392. doi: 10.1016/j.jconrel.2016.06.022. Epub 2016 Jun 11.

24.

Building Noncommunicable Disease Research Capacity in the South Asian Region: The ASCEND Program.

Oldenburg B, Wickramasinghe K, Byrnes A.

Asia Pac J Public Health. 2016 Jan;28(1 Suppl):6S-9S. doi: 10.1177/1010539515625248. No abstract available.

PMID:
26792912
25.

Likelihood-based complex trait association testing for arbitrary depth sequencing data.

Yan S, Yuan S, Xu Z, Zhang B, Zhang B, Kang G, Byrnes A, Li Y.

Bioinformatics. 2015 Sep 15;31(18):2955-62. doi: 10.1093/bioinformatics/btv307. Epub 2015 May 14.

26.

Loss of the RNA polymerase III repressor MAF1 confers obesity resistance.

Bonhoure N, Byrnes A, Moir RD, Hodroj W, Preitner F, Praz V, Marcelin G, Chua SC Jr, Martinez-Lopez N, Singh R, Moullan N, Auwerx J, Willemin G, Shah H, Hartil K, Vaitheesvaran B, Kurland I, Hernandez N, Willis IM.

Genes Dev. 2015 May 1;29(9):934-47. doi: 10.1101/gad.258350.115.

27.

Two novel disease-causing variants in BMPR1B are associated with brachydactyly type A1.

Racacho L, Byrnes AM, MacDonald H, Dranse HJ, Nikkel SM, Allanson J, Rosser E, Underhill TM, Bulman DE.

Eur J Hum Genet. 2015 Dec;23(12):1640-5. doi: 10.1038/ejhg.2015.38. Epub 2015 Mar 11.

28.

Impact of natural IgM concentration on gene therapy with adenovirus type 5 vectors.

Qiu Q, Xu Z, Tian J, Moitra R, Gunti S, Notkins AL, Byrnes AP.

J Virol. 2015 Mar;89(6):3412-6. doi: 10.1128/JVI.03217-14. Epub 2014 Dec 31.

29.

Treatment of dyslipidemia.

Tonkin A, Byrnes A.

F1000Prime Rep. 2014 Mar 3;6:17. doi: 10.12703/P6-17. eCollection 2014. Review.

30.

The value of statistical or bioinformatics annotation for rare variant association with quantitative trait.

Byrnes AE, Wu MC, Wright FA, Li M, Li Y.

Genet Epidemiol. 2013 Nov;37(7):666-74. doi: 10.1002/gepi.21747. Epub 2013 Jul 8.

31.

Coagulation factor X shields adenovirus type 5 from attack by natural antibodies and complement.

Xu Z, Qiu Q, Tian J, Smith JS, Conenello GM, Morita T, Byrnes AP.

Nat Med. 2013 Apr;19(4):452-7. doi: 10.1038/nm.3107. Epub 2013 Mar 24.

PMID:
23524342
32.

Circulating antibodies and macrophages as modulators of adenovirus pharmacology.

Khare R, Hillestad ML, Xu Z, Byrnes AP, Barry MA.

J Virol. 2013 Apr;87(7):3678-86. doi: 10.1128/JVI.01392-12. Epub 2013 Jan 16.

33.

Photonic chip based tunable and reconfigurable narrowband microwave photonic filter using stimulated Brillouin scattering.

Byrnes A, Pant R, Li E, Choi DY, Poulton CG, Fan S, Madden S, Luther-Davies B, Eggleton BJ.

Opt Express. 2012 Aug 13;20(17):18836-45. doi: 10.1364/OE.20.018836.

PMID:
23038523
34.

Design for broadband on-chip isolator using Stimulated Brillouin Scattering in dispersion-engineered chalcogenide waveguides.

Poulton CG, Pant R, Byrnes A, Fan S, Steel MJ, Eggleton BJ.

Opt Express. 2012 Sep 10;20(19):21235-46. doi: 10.1364/OE.20.021235.

PMID:
23037247
35.

Photonic-chip-based tunable slow and fast light via stimulated Brillouin scattering.

Pant R, Byrnes A, Poulton CG, Li E, Choi DY, Madden S, Luther-Davies B, Eggleton BJ.

Opt Lett. 2012 Mar 1;37(5):969-71.

PMID:
22378455
36.

Breakout session C summary: current virus detection methods.

Byrnes AP, Willkommen H.

PDA J Pharm Sci Technol. 2011 Nov-Dec;65(6):660-2. doi: 10.5731/pdajpst.2011.00835.

PMID:
22294593
37.

The role of endosomal escape and mitogen-activated protein kinases in adenoviral activation of the innate immune response.

Smith JS, Xu Z, Tian J, Palmer DJ, Ng P, Byrnes AP.

PLoS One. 2011;6(10):e26755. doi: 10.1371/journal.pone.0026755. Epub 2011 Oct 27.

38.

To identify associations with rare variants, just WHaIT: Weighted haplotype and imputation-based tests.

Li Y, Byrnes AE, Li M.

Am J Hum Genet. 2010 Nov 12;87(5):728-35. doi: 10.1016/j.ajhg.2010.10.014. Epub 2010 Nov 4. Erratum in: Am J Hum Genet. 2011 Jan 7;88(1):122.

39.

Phase I and pharmacokinetic studies of CYT-6091, a novel PEGylated colloidal gold-rhTNF nanomedicine.

Libutti SK, Paciotti GF, Byrnes AA, Alexander HR Jr, Gannon WE, Walker M, Seidel GD, Yuldasheva N, Tamarkin L.

Clin Cancer Res. 2010 Dec 15;16(24):6139-49. doi: 10.1158/1078-0432.CCR-10-0978. Epub 2010 Sep 27.

40.

Mutations in GDF5 presenting as semidominant brachydactyly A1.

Byrnes AM, Racacho L, Nikkel SM, Xiao F, MacDonald H, Underhill TM, Bulman DE.

Hum Mutat. 2010 Oct;31(10):1155-62. doi: 10.1002/humu.21338.

PMID:
20683927
41.

Complete remission of unresectable hepatocellular carcinoma treated with reduced dose of sorafenib: a case report.

Wang SX, Byrnes A, Verma S, Pancoast JR, Rixe O.

Target Oncol. 2010 Mar;5(1):59-63. doi: 10.1007/s11523-010-0133-x. Epub 2010 Mar 23.

PMID:
20309643
42.

Induction of shock after intravenous injection of adenovirus vectors: a critical role for platelet-activating factor.

Xu Z, Smith JS, Tian J, Byrnes AP.

Mol Ther. 2010 Mar;18(3):609-16. doi: 10.1038/mt.2009.279. Epub 2009 Dec 1.

43.

Gene expression in peripheral blood leukocytes in monozygotic twins discordant for chronic fatigue: no evidence of a biomarker.

Byrnes A, Jacks A, Dahlman-Wright K, Evengard B, Wright FA, Pedersen NL, Sullivan PF.

PLoS One. 2009 Jun 5;4(6):e5805. doi: 10.1371/journal.pone.0005805.

44.

Adenovirus activates complement by distinctly different mechanisms in vitro and in vivo: indirect complement activation by virions in vivo.

Tian J, Xu Z, Smith JS, Hofherr SE, Barry MA, Byrnes AP.

J Virol. 2009 Jun;83(11):5648-58. doi: 10.1128/JVI.00082-09. Epub 2009 Mar 25.

45.

Brachydactyly A-1 mutations restricted to the central region of the N-terminal active fragment of Indian Hedgehog.

Byrnes AM, Racacho L, Grimsey A, Hudgins L, Kwan AC, Sangalli M, Kidd A, Yaron Y, Lau YL, Nikkel SM, Bulman DE.

Eur J Hum Genet. 2009 Sep;17(9):1112-20. doi: 10.1038/ejhg.2009.18. Epub 2009 Mar 11.

46.

Clearance of adenovirus by Kupffer cells is mediated by scavenger receptors, natural antibodies, and complement.

Xu Z, Tian J, Smith JS, Byrnes AP.

J Virol. 2008 Dec;82(23):11705-13. doi: 10.1128/JVI.01320-08. Epub 2008 Sep 24.

47.

Immune activation and IL-12 production during acute/early HIV infection in the absence and presence of highly active, antiretroviral therapy.

Byrnes AA, Harris DM, Atabani SF, Sabundayo BP, Langan SJ, Margolick JB, Karp CL.

J Leukoc Biol. 2008 Dec;84(6):1447-53. doi: 10.1189/jlb.0708438. Epub 2008 Sep 19.

48.

Th1 cytokines are upregulated by adenoviral vectors in the brains of primed mice.

Lee MB, McMenamin MM, Byrnes AP, Charlton HM, Wood MJ.

Neuroreport. 2008 Aug 6;19(12):1187-92. doi: 10.1097/WNR.0b013e3283088e3d.

PMID:
18628662
49.

Interaction of systemically delivered adenovirus vectors with Kupffer cells in mouse liver.

Smith JS, Xu Z, Tian J, Stevenson SC, Byrnes AP.

Hum Gene Ther. 2008 May;19(5):547-54. doi: 10.1089/hum.2008.004.

PMID:
18447633
50.

A quantitative assay for measuring clearance of adenovirus vectors by Kupffer cells.

Smith JS, Xu Z, Byrnes AP.

J Virol Methods. 2008 Jan;147(1):54-60. Epub 2007 Sep 11.

PMID:
17850893

Supplemental Content

Loading ...
Support Center